Computing in the Age of the $1000 Genome: Xconomy to Convene Next Big SF Event Oct. 24

An amazing innovation story has been unfolding the past few years in the field of gene sequencing, which is creating one of today’s biggest computing challenges. New DNA sequencing tools are improving at such a rapid pace that scientists say it will soon be possible to generate the 3-billion-letter signature of an individual’s DNA for $1,000, and possibly in as little as 15 minutes. This is the essential stuff scientists say can help bring about the era of personalized medicine.

Much of this innovation is occurring here in the U.S., and few places other than Silicon Valley have the necessary computing and biotech chops to pull this off. So Xconomy is excited to announce that we are bringing together some of the world leaders in this emerging field for a half-day summit on October 24 in San Francisco, titled “Computing in the Age of the $1,000 Genome.

We have a stellar lineup of entrepreneurs, scientists, and investors who will come together to discuss this challenge in a series of interactive, moderated chats. Here’s who is confirmed so far:

Hugh Martin, CEO, Pacific Biosciences

Cliff Reid, CEO, Complete Genomics

Atul Butte, Associate Professor, Stanford University School of Medicine

Sue Siegel, General Partner, Mohr Davidow Ventures

Ashley Dombkowski, Chief Business Officer, 23andMe

Sujal Patel, President, Isilon Storage Division, EMC

Andreas Sundquist, CEO, DNAnexus

Jim Karkanias, Senior Director, Applied Research and Technology, Microsoft Health Solutions

Rob Arnold, General Manager, Geospiza business unit, PerkinElmer

Tim Hunkapiller, Consultant, Life Technologies

There are still major barriers standing in the way of a future based on genomic medicine, and we will plan to cover that territory. For starters, the genomic data will need to be stored, secured, backed up, analyzed, and visualized for scientists to make much sense of it all. And we will be sure to touch on some important implications of all this genomics work, for medicine and society at large.

This event will take place from 2 pm to 6:30 pm on Monday, October 24, at the Byers Auditorium on UCSF’s Mission Bay campus. You can find more information on how to save a seat at the super saver discount rate by clicking here. I’m looking forward to this one. See you there on October 24.

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.